Northwestern Medicine scientists have demonstrated that an enzyme called IDH1 plays a significant role in cancer progression and may be a target for novel drug therapies.
Northwestern Medicine scientists have discovered that a unique population of immune cells play a key role in the development of pulmonary fibrosis, a fatal lung disease.
Scientists have designed a promising bioactive nanomaterial with the potential to stimulate bone regeneration and improve quality of life for surgical patients and lead to less-invasive procedures.
A recent seminar explored the topic of innovation in medical education and the role of mastery learning in training of the next generation of physicians.
A new study finds that patients with double-hit lymphoma who received autologous stem cell transplantation saw no survival benefit, compared to patients who did not undergo the procedure.
Northwestern Medicine scientists have developed technology that uses genomics and data analytics to efficiently screen for molecules produced by molds to find new drug prospects.
The Northwestern community gathered to celebrate as a ceremonial steel beam was set in place atop the Louis A. Simpson and Kimberly K. Querrey Biomedical Research Center.
Northwestern recently celebrated the 10-year anniversary of the creation of the Healthcare Quality and Patient Safety program, the first graduate-level program in the field.
A cancer drug for certain types of leukemia and lymphoma can also prevent reactions to some of the most common airborne allergies, according to a recent Northwestern Medicine study.
Michael Musharbash, a second-year medical student, has received a Schweitzer Fellowship to implement educational services for LGBT and homeless youth at the Center on Halsted.